Tao YN, Han Q, Jiao W, Yang LK, Wang F, Xue S, Shen M, Wang YH. Effects of ulinastatin therapy in deep vein thrombosis prevention after brain tumor surgery: A single-center randomized controlled trial. World J Clin Cases 2023; 11(31): 7583-7592 [PMID: 38078125 DOI: 10.12998/wjcc.v11.i31.7583]
Reader's ID:
06082561
Submitted on:
November 13, 2023, 13:18
Reader Expertise:
Reader’s expertise on the topic of the manuscript
Conflicts-of-Interest Statement:
Does the reader have a conflict of interest?
Reader Comment Standards for Published Articles:
1 Title
Does the title reflect the main subject/hypothesis of the manuscript?
2 Abstract
Does the abstract summarize and reflect the work described in the manuscript?
3 Key Words
Do the key words reflect the focus of the manuscript?
4 Background
Does the manuscript adequately describe the background, present status and significance of the study?
5 Methods
Does the manuscript describe methods (e.g., experiments, data analysis, surveys, and clinical trials, etc.) in adequate detail?
6 Results
Are the research objectives achieved by the experiments used in this study?
Has the study made meaningful contributions towards research progress in this field?
7 Discussion
Does the manuscript interpret the findings adequately and appropriately, highlighting the key points concisely, clearly and logically?
Are the findings and their applicability/relevance to the literature stated in a clear and definite manner?
Is the Discussion accurate and does it discuss the paper’s scientific significance and/or relevance to clinical practice sufficiently?
8 Illustrations and Tables
Are the figures, diagrams and tables sufficient, good quality and appropriately illustrative of the paper contents?
Do figures require labeling with arrows, asterisks, etc., or better legends?
9 Biostatistics
Does the manuscript meet the requirements of biostatistics?
10 Units
Does the manuscript meet the requirements of use of SI units?
11 References
Does the manuscript appropriately cite the latest, important and authoritative references in the Introduction and Discussion sections?
Does the author self-cite, omit, incorrectly cite and/or over-cite references?
12 Quality of manuscript organization and presentation
Is the manuscript concisely and coherently organized and presented?
Are the style, language and grammar accurate and appropriate?
13 Ethics statements
For all manuscripts involving human studies and/or animal experiments, author(s) must submit the related formal ethics documents that were reviewed and approved by their local ethical review committee. Did the manuscript meet the requirements of ethics?
Scientific Quality:
The overall quality of the manuscript, based on the above-listed criteria, should be evaluated and classified according to the following five categories
Language Quality:
Language quality (style, grammar, and spelling) should be evaluated and classified according to the following five categories.
Reader Comments:
In the study, the authors conducted a single-center randomized controlled trial to assess the effectiveness of ulinastatin therapy in preventing DVT. The trial involved a study group receiving ulinastatin therapy and a control group receiving standard treatment. The primary outcome measured was the incidence of DVT after brain tumor surgery.
The use of ulinastatin therapy for DVT prevention is an interesting topic considering the potential risks and complications associated with DVT after surgical procedures. The study design, a randomized controlled trial, is generally considered a robust method for evaluating treatment effectiveness.
Upon review, the authors found that ulinastatin therapy showed a significant reduction in the incidence of DVT compared to the control group. This finding suggests that ulinastatin therapy may be a promising intervention in preventing DVT after brain tumor surgery. However, it is important to consider the limitations of a single-center study, such as potential biases and limited generalizability to other populations.
While this research provides valuable insights into the potential benefits of ulinastatin therapy, further studies with larger sample sizes and multi-center collaborations are warranted to confirm and generalize these findings. Additionally, a more in-depth analysis of the safety profile and potential adverse effects associated with ulinastatin therapy would be valuable for a comprehensive evaluation.
Overall, this study contributes to the existing knowledge on DVT prevention after brain tumor surgery, suggesting that ulinastatin therapy could be a promising strategy. Clinicians and researchers in the field should consider these findings when designing future studies or clinical guidelines related to DVT prevention in neurosurgical patients.
Reply from the Editorial Office:
First, thank you very much for your professional comments on the article published in World Journal of Clinical Cases.
Second, we read your comments with great interest. You are welcome to format your valuable comments into a Letter to the Editor and submit it online to World Journal of Clinical Cases at https://www.f6publishing.com. There are no restrictions on the number of words, figures (color, B/W) or authors for a Letter to the Editor. In addition, the article processing charge will be exempted for this Letter to the Editor. As with all articles published by the Baishideng Publishing Group, the Letter to the Editor will be published online after completing peer review. The guidelines for a Letter to the Editor can be found at: https://www.wjgnet.com/bpg/GerInfo/219.
Finally, we look forward to receiving your high-quality Letter to the Editor, which will promote academic communication and lead the development of this discipline.